wr 1065 has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hall, EJ; Hei, TK; Piao, CQ; Willey, JC; Wu, LJ | 1 |
| Grdina, DJ; Hunter, N; Kataoka, Y; Milas, L; Murley, JS; Weichselbaum, RR | 1 |
2 other study(ies) available for wr 1065 and Lung Neoplasms
| Article | Year |
|---|---|
Genomic instability and tumorigenic induction in immortalized human bronchial epithelial cells by heavy ions.
Topics: Alpha Particles; Animals; Antineoplastic Agents; Aspartic Acid; Bronchi; Cell Fusion; Cell Line, Transformed; Cell Transformation, Neoplastic; Epithelial Cells; Gene Amplification; Genes, Tumor Suppressor; Heavy Ions; Humans; Iron; Linear Energy Transfer; Lung Neoplasms; Mercaptoethylamines; Mice; Mice, Nude; Phosphonoacetic Acid; Radiation-Protective Agents; Tumor Cells, Cultured | 1998 |
Inhibition of spontaneous metastases formation by amifostine.
Topics: Amifostine; Angiostatins; Animals; Blotting, Western; Cell Division; Dose-Response Relationship, Drug; Lung Neoplasms; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mercaptoethylamines; Mice; Mice, Inbred C3H; Muscle Neoplasms; Neoplasm Invasiveness; Peptide Fragments; Plasminogen; Radiation-Protective Agents; Sarcoma, Experimental; Xenograft Model Antitumor Assays | 2002 |